Form 4: Lexaria Bioscience Corp. Director Catherine C. Turkel Reports Transaction
SEC Form 4
Director Catherine C. Turkel reports a transaction involving Lexaria Bioscience Corp. common shares and stock options.
Summary
- On July 26, 2024, Catherine C. Turkel, a director of Lexaria Bioscience Corp., reported a transaction.
- The transaction involved the disposition of 1,500 common shares.
- Turkel also acquired 12,000 stock options with an exercise price of $3.39, exercisable from July 26, 2024, to July 26, 2029.
- Following the reported transactions, Turkel directly owns 3,400 stock options (exercisable at $3.04 expiring 09/02/2027), 5,000 stock options (exercisable at $1.96 expiring 10/12/2027), 10,000 stock options (exercisable at $0.87 expiring 07/25/2028), 15,000 stock options (exercisable at $2.36 expiring 04/26/2029), and 27,000 stock options (exercisable at $3.39 expiring 07/26/2029).
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company insider. The sentiment is neutral as it simply reports facts without expressing any positive or negative outlook.
Negatives
- Catherine C. Turkel disposed of 1,500 common shares.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 09/02/2022 | Date of stock options exercisable at $3.04 |
| 09/02/2027 | Expiration date of stock options exercisable at $3.04 |
| 10/12/2022 | Date of stock options exercisable at $1.96 |
| 10/12/2027 | Expiration date of stock options exercisable at $1.96 |
| 07/25/2023 | Date of stock options exercisable at $0.87 |
| 07/25/2028 | Expiration date of stock options exercisable at $0.87 |
| 04/26/2024 | Date of stock options exercisable at $2.36 |
| 04/26/2029 | Expiration date of stock options exercisable at $2.36 |
| 07/26/2024 | Date of transaction and date of stock options exercisable at $3.39 |
| 07/26/2029 | Expiration date of stock options exercisable at $3.39 |
| 07/30/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.